- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07782060
Feasibility Randomised Controlled Trial Exploring Implementation of the Compassionate Mindful rEsilience pRogram for People With pUlmonaRY Fibrosis: The MERcURY Study (MERcURY)
Pulmonary fibrosis (PF) is a chronic lung condition in which scar tissue gradually forms, impairing oxygen transfer and causing breathlessness. Individuals with PF frequently experience anxiety and depression, yet supportive care remains underdeveloped, and few evidence-based psychological interventions exist for this population, representing a critical gap in care.
This feasibility randomised controlled trial (RCT) evaluated the Compassionate Mindful Resilience (CMR) programme, a 4-week online, nurse-led mindfulness-based intervention designed to improve psychological outcomes in people living with PF.
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Background: Pulmonary fibrosis is a progressive, irreversible fibrotic lung disease that requires long-term treatment. People with a diagnosis of pulmonary fibrosis are known to have reduced health-related quality of life, furthermore, it is common for such individuals to experience anxiety and depression. Therefore, interventions to support these individuals are essential to improve their psychological health. Mindfulness is increasing in popularity but retention in these programmes can be challenging. Condensed programmes have great potential but require statistical and individual evaluation. The Compassionate Mindful Resilience Program is a 4-week course that teaches simple, effective, evidence-based practices, skills and techniques.
Methods: This study aims to establish the feasibility of a randomised controlled trial to evaluate the effectiveness of the Compassionate Mindful Resilience Program in improving the psychosocial well-being of people with a diagnosis of pulmonary fibrosis. The trial will be conducted to test procedures, outcomes and validated tools; estimate recruitment and attrition rates; and calculate the sample size required for a future definitive multi-centre randomised controlled trial. The study will also utilise qualitative methods to explore the acceptability of the intervention to the study population. In keeping with CONSORT guidelines. The SPIRIT guidelines and checklist will be utilised to report the study.
Discussion: This study will implement a four-week mindfulness intervention and its utility for people with Pulmonary Fibrosis. The investigators aim to increase equitable access to evidence-based mindfulness practices with the potential to improve the lives of people impacted by this condition. If the study demonstrates the practicability of delivering the online 4-week Compassionate Mindful Resilience program with adequate recruitment, the investigators will be able to determine the feasibility of progression to a randomised controlled clinical trial to increase equitable access to evidence-based mindfulness practices with the potential to improve the lives of people impacted by Pulmonary Fibrosis.
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Please Select
-
Belfast, Please Select, Regno Unito, BT7 1NN
- Queen's University Belfast
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- have a confirmed diagnosis of PF
- be aged 18 years or older
- reside in the UK or Ireland
- have the capacity to provide informed consent
- demonstrate a commitment to attend all four CMR sessions (demonstrated through discussion with the mindfulness teacher during screening)
- have access to an internet-enabled device.
Exclusion Criteria:
- No diagnosis of PF
- under 18 years old
- live outside of UK or Ireland
- no capacity to provide informed consent
- not willing to attend all four CMR sessions
- no access to an internet-enabled device.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Terapia di supporto
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Intervention group
CMR is an internationally accredited 4-week programme with 2-hour online sessions delivered via Microsoft Teams
|
It is an internationally accredited 4-week programme with 2-hour online sessions delivered via Microsoft Teams
|
|
Nessun intervento: Waitlist group
This group did not receive the CMR intervention until all intervention groups had completed CMR.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Feasibility of the intervention
Lasso di tempo: From enrollment until the follow up interview was completed (up to 10 weeks)
|
Adherence
|
From enrollment until the follow up interview was completed (up to 10 weeks)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
The feasibility of collecting data on anxiety, depression, well-being, mindfulness, resilience, and self-compassion
Lasso di tempo: Baseline (week 1), post-CMR (week 4), and four-week follow-up (week 8)
|
These were measured via online surveys at baseline, post-CMR, and four-week follow-up
|
Baseline (week 1), post-CMR (week 4), and four-week follow-up (week 8)
|
Altre misure di risultato
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Feasibility of recruitment and retention
Lasso di tempo: From recruitment until the end of the study (up to 5 months)
|
Measured against pre-defined recruitment and retention targets
|
From recruitment until the end of the study (up to 5 months)
|
Collaboratori e investigatori
Sponsor
Pubblicazioni e link utili
Pubblicazioni generali
- Mc Veigh C, Reid J, Larkin P, Porter S, Hudson P. Palliative care for people with non-malignant respiratory disease and their carers: a review of the current evidence. J Res Nurs. 2019 Sep;24(6):420-430. doi: 10.1177/1744987119840066. Epub 2019 Apr 29.
- Mc Veigh C, Reid J, Larkin P, Porter S, Hudson P. The experience of palliative care service provision for people with non-malignant respiratory disease and their family carers: An all-Ireland qualitative study. J Adv Nurs. 2018 Feb;74(2):383-394. doi: 10.1111/jan.13453. Epub 2017 Nov 27.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- MHLS 24_139
- SB\ZA\101010662\980079 (Altro numero di sovvenzione/finanziamento: The Burdett Trust)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .